Xarelto and Mircera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xarelto (rivaroxaban) and Mircera (methoxy polyethylene glycol-epoetin beta). Common drug interactions include acute pulmonary oedema among females and altered state of consciousness among males.

The phase IV clinical study analyzes what interactions people have when they take Xarelto and Mircera. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Xarelto?

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 212,377 Xarelto users. Check the latest studies of Xarelto.

What is Mircera?

Mircera has active ingredients of methoxy polyethylene glycol-epoetin beta. eHealthMe is studying from 10,321 Mircera users. Check the latest studies of Mircera.

On Jul, 07, 2026

13 people who take Xarelto and Mircera together, and have interactions are studied.

What are the common drug interactions of Xarelto and Mircera, by gender? *:

female:

Acute pulmonary oedema (sudden deposit of fluid in the lung))
Ankle fracture
Cardiac failure
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Constipation
Diabetic foot
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Hyperkalaemia (damage to or disease of the kidney)
Hypokalaemia (low potassium)

male:

Altered state of consciousness (altered state of mind)
Anaemia (lack of blood)
Device related infection
Dizziness
Dysphagia (a condition in which swallowing is difficult or painful)
Fall
General physical health deterioration (weak health status)
Injection site haematoma (localized swelling filled with blood at injection site)
Nephrogenic anaemia (anaemia due to kidney disease)
Neutropenia (an abnormally low number of neutrophils)

What are the common drug interactions of Xarelto and Mircera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Acute respiratory failure

60+:

Acute pulmonary oedema (sudden deposit of fluid in the lung))
Ankle fracture
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Oedema peripheral (superficial swelling)
Post thrombotic syndrome (long-term effects that can occur after venous thrombosis)
Anaemia (lack of blood)
Gastric ulcer (stomach ulcer)
Lung disorder (lung disease)
Malignant neoplasm progression (cancer tumour came back)

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 7 people, 53.85%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 15.38%
Chronic Kidney Disease: 2 people, 15.38%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 15.38%
Insomnia (sleeplessness): 2 people, 15.38%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 15.38%
Heart Attack: 2 people, 15.38%
Eosinophilic Pneumonia (eosinophil accumulates in the lung): 1 person, 7.69%
Constipation: 1 person, 7.69%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Xarelto and Mircera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously